Equibles does not estimate personal net worth.
Get an email with a short summary when Zeo ScientifiX, Inc. publishes a filing, an earnings call transcript or a press release.
Get ZEOX alertsMatthew Sinnreich is recorded as Board Member at Zeo ScientifiX, Inc. (ZEOX) since September 23, 2022 and CEO and COO at Zeo ScientifiX, Inc. (ZEOX) since July 21, 2022. Zeo ScientifiX, Inc. reported in an 8-K filed December 1, 2022 that Matthew Sinnreich resigned as member of the Company’s Board of Directors, effective November 29, 2022. Zeo ScientifiX, Inc. reported in an 8-K filed December 1, 2022 that Matthew Sinnreich resigned as Acting Chief Executive Officer and President, effective November 29, 2022. Zeo ScientifiX, Inc. reported in an 8-K filed September 27, 2022 that Matthew Sinnreich was appointed director, effective September 23, 2022. Equibles holds 6 filed executive changes naming Matthew Sinnreich; each is listed under recent activity with its source filing. Zeo ScientifiX, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zeo ScientifiX, Inc. includes Harry Leider (CEO), Harry Leider, M.D., M.B.A. (CEO and Board Member), Ian Bothwell (CEO and Board Member) and 7 others.
“On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.”
“On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.”
2022-09-23–present
SEC 8-K
2022-09-13–present
2022-07-21–present
2022-07-21–present
2022-08-19–2022-11-29
2022-07-21–2022-11-29
ZEOX
Biotechnology · Healthcare
Board Member, CEO, COO
2022-07-21–present
